OBJECTIVE: Platelets play a dual role in thrombosis by forming aggregates and stimulating coagulation. We investigated the commitment of platelets to these separate functions during collagen-induced thrombus formation in vitro and in vivo. METHODS AND RESULTS: High-resolution 2-photon fluorescence microscopy revealed that in thrombus formation under flow, fibrin(ogen)-binding platelets assembled into separate aggregates, whereas distinct patches of nonaggregated platelets exposed phosphatidylserine. The latter platelet population had inactivated alphaIIb beta3 integrins and displayed increased binding of coagulation factors. Coated platelets, expressing serotonin binding sites, were not identified as a separate population. Thrombin generation and coagulation favored the transformation to phosphatidylserine-exposing platelets with inactivated integrins and reduced adhesion. Prolonged tyrosine phosphorylation in vitro resulted in secondary downregulation of active alphaIIb beta3. CONCLUSIONS: These results lead to a new spatial model of thrombus formation, in which aggregated platelets ensure thrombus stability, whereas distinct patches of nonaggregated platelets effectuate procoagulant activity and generate thrombin and fibrin. Herein, the hemostatic activity of a developing thrombus is determined by the balance in formation of proaggregatory and procoagulant platelets. This balance is influenced by antiplatelet and anticoagulant medication.
OBJECTIVE: Platelets play a dual role in thrombosis by forming aggregates and stimulating coagulation. We investigated the commitment of platelets to these separate functions during collagen-induced thrombus formation in vitro and in vivo. METHODS AND RESULTS: High-resolution 2-photon fluorescence microscopy revealed that in thrombus formation under flow, fibrin(ogen)-binding platelets assembled into separate aggregates, whereas distinct patches of nonaggregated platelets exposed phosphatidylserine. The latter platelet population had inactivated alphaIIb beta3 integrins and displayed increased binding of coagulation factors. Coated platelets, expressing serotonin binding sites, were not identified as a separate population. Thrombin generation and coagulation favored the transformation to phosphatidylserine-exposing platelets with inactivated integrins and reduced adhesion. Prolonged tyrosine phosphorylation in vitro resulted in secondary downregulation of active alphaIIb beta3. CONCLUSIONS: These results lead to a new spatial model of thrombus formation, in which aggregated platelets ensure thrombus stability, whereas distinct patches of nonaggregated platelets effectuate procoagulant activity and generate thrombin and fibrin. Herein, the hemostatic activity of a developing thrombus is determined by the balance in formation of proaggregatory and procoagulant platelets. This balance is influenced by antiplatelet and anticoagulant medication.
Authors: Pia R-M Siljander; Imke C A Munnix; Peter A Smethurst; Hans Deckmyn; Theo Lindhout; Willem H Ouwehand; Richard W Farndale; Johan W M Heemskerk Journal: Blood Date: 2003-10-16 Impact factor: 22.113
Authors: Imke C A Munnix; Marjan Harmsma; John C Giddings; Peter W Collins; Marion A H Feijge; Paul Comfurius; Johan W M Heemskerk; Edouard M Bevers Journal: Thromb Haemost Date: 2003-04 Impact factor: 5.249
Authors: Ammon M Fager; Jeremy P Wood; Beth A Bouchard; Ping Feng; Paula B Tracy Journal: Arterioscler Thromb Vasc Biol Date: 2010-11-11 Impact factor: 8.311
Authors: Anastasia A Abaeva; Matthias Canault; Yana N Kotova; Sergey I Obydennyy; Alena O Yakimenko; Nadezhda A Podoplelova; Vladimir N Kolyadko; Herve Chambost; Aleksei V Mazurov; Fazoil I Ataullakhanov; Alan T Nurden; Marie-Christine Alessi; Mikhail A Panteleev Journal: J Biol Chem Date: 2013-08-30 Impact factor: 5.157
Authors: Judith M E M Cosemans; Saskia E M Schols; Lucia Stefanini; Susanne de Witt; Marion A H Feijge; Karly Hamulyák; Hans Deckmyn; Wolfgang Bergmeier; Johan W M Heemskerk Journal: Blood Date: 2010-10-29 Impact factor: 22.113
Authors: Wolfgang Bergmeier; Masatsugu Oh-Hora; Christie-Ann McCarl; R Claire Roden; Paul F Bray; Stefan Feske Journal: Blood Date: 2008-10-24 Impact factor: 22.113
Authors: Shauna L French; Claudia Thalmann; Paul F Bray; Lynn E Macdonald; Andrew J Murphy; Mark W Sleeman; Justin R Hamilton Journal: Blood Adv Date: 2018-06-12
Authors: Frauke Swieringa; Marijke J E Kuijpers; Moniek M E Lamers; Paola E J van der Meijden; Johan W M Heemskerk Journal: Haematologica Date: 2015-03-13 Impact factor: 9.941
Authors: Shawn M Jobe; Katina M Wilson; Lorie Leo; Alejandro Raimondi; Jeffery D Molkentin; Steven R Lentz; Jorge Di Paola Journal: Blood Date: 2007-11-07 Impact factor: 22.113
Authors: Olga Konopatskaya; Karen Gilio; Matthew T Harper; Yan Zhao; Judith M E M Cosemans; Zubair A Karim; Sidney W Whiteheart; Jeffery D Molkentin; Paul Verkade; Steve P Watson; Johan W M Heemskerk; Alastair W Poole Journal: J Clin Invest Date: 2009-01-19 Impact factor: 14.808